Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 14, 2012; 18(34): 4744-4750
Published online Sep 14, 2012. doi: 10.3748/wjg.v18.i34.4744
Published online Sep 14, 2012. doi: 10.3748/wjg.v18.i34.4744
Table 2 Correlation of nuclear factor-κB RelA and level of target genes (mean ± SD)
| Nuclear factor-κB | P | ||
| - (n = 66) | + (n = 49) | ||
| IL-6 (pg/mL) | 8.1 ± 8.6 | 11.8 ± 10.7 | 0.044 |
| VEGF (pg/mL) | 117.2 ± 154.2 | 178.9 ± 202.7 | 0.066 |
| SAA (mg/mL) | 8.1 ± 20.3 | 14.5 ± 16.3 | 0.072 |
| CRP (mg/mL) | 0.1 ± 0.1 | 0.3 ± 0.4 | 0.010 |
- Citation: Kwon HC, Kim SH, Oh SY, Lee S, Lee JH, Jang JS, Kim MC, Kim KH, Kim SJ, Kim SG, Kim HJ. Clinicopathologic significance of expression of nuclear factor-κB RelA and its target gene products in gastric cancer patients. World J Gastroenterol 2012; 18(34): 4744-4750
- URL: https://www.wjgnet.com/1007-9327/full/v18/i34/4744.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i34.4744